In NASH, circulating miR-122 was reported to be upregulated and suggested as a potential prognosis biomarker.46,48,54 There are emerging data highlighting that PNPLA3, MBOAT7, and STAT3 affect the occurrence and development of MAFLD. Here, STAT3 is linked to metabolic dysfunction-associated steatohepatitis.